Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.88
(
-0.64%
)
Bitcoin
79,053.00
(
0.51%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: EYEBUYSTOX post# 170698

Monday, 03/31/2014 11:24:07 AM

Monday, March 31, 2014 11:24:07 AM

Post# of 347009
Scotts partner Kyle Dennis seemed to have an interest in PPHM back in January

Kyle Dennis
@kylewdennis

Identifying Undervalued and Under the Radar Biotechs. By following this twitter account you are agreeing to this disclaimer: stockmatusow.com/disclaimer/


Kyle Dennis @kylewdennis 2014-01-13T18:46:07-06:00 RT @BiotechMoney18: $$$ 1/14 BIOTECH watchlist: $CHTP $AMRN $BIOD $PPHM $BAXS $DNDN $IDRA $MSTX $RNN $ARNA $CBMX $ADXS $$$
Reply Retweet Favorite


https://twitter.com/kylewdennis

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote